Lumentum (LITE) Stock Down 16%: Should Investors Buy the AI Dip?

Key Takeaways

Table of Contents

LITE shares started trading at $732.82, declining approximately 16% in the past month and 18% over three months, despite climbing 3.8% in one session following analyst upgrades
Third-quarter fiscal 2026 revenue reached $808.4 million, marking a 90.1% year-over-year increase, while EPS of $2.37 exceeded consensus by $0.10
Management projects Q4 2026 EPS between $2.85 and $3.05; analysts forecast full-year EPS at $6.42
Analyst consensus leans toward Moderate Buy with a mean price target of $1,012.67, suggesting significant upside from present levels
Institutions control 94.05% of shares, with multiple new Q1 stakes; company insiders offloaded $38.8 million in stock during the last three months

Lumentum Holdings (LITE) began Friday’s session at $732.82, trading substantially beneath its 50-day moving average of $865.06, despite receiving a series of bullish analyst upgrades that drew renewed investor interest.

Lumentum Holdings Inc., LITE

Shares climbed 3.8% during that particular trading day after the upgrades were announced, yet this temporary rally hasn’t reversed the broader downtrend. The stock remains approximately 16% lower over the past 30 days and 18% down across the trailing 90-day period.

This decline appears counterintuitive given the company’s robust quarterly performance. During Q3 of fiscal year 2026, Lumentum delivered revenue of $808.4 million, representing a 90.1% surge compared to the same period last year. Earnings per share reached $2.37, surpassing Wall Street’s consensus forecast of $2.27 by ten cents.

Looking ahead to Q4 2026, management provided EPS guidance ranging from $2.85 to $3.05. The analyst community collectively anticipates full-year earnings per share of $6.42.

The stock currently trades at a price-to-earnings multiple of 135.71x, significantly exceeding the US Communications sector average of 31.7x. This valuation premium has become a focal point in ongoing debates about whether shares are appropriately priced.

Wall Street Price Targets Point Higher

Analysts covering the stock have established an average price objective of $1,012.67, implying approximately 38% potential upside from today’s trading level. Among 21 Wall Street analysts tracking the company, 14 maintain Buy ratings while seven hold neutral stances.

Stifel lifted its price target from $800 to $1,100 while maintaining a Buy rating. Northland Securities established a $1,200 target with an Outperform designation. Jefferies similarly holds a $1,200 price objective. On Thursday, Citigroup confirmed its Buy stance and placed LITE on a 90-day catalyst watch list.

However, not all voices share the same optimism. Zacks downgraded the stock from Strong Buy to Hold on July 6th, while UBS maintains a Hold rating — representing notable contrarian perspectives amid predominantly bullish sentiment.

One discounted cash flow analysis calculates intrinsic value at $1,026.15 using projected future cash flows. An alternative, more optimistic DCF model suggests fair value could reach $5,085.95 — though achieving this target would require sustained, exceptional revenue growth over an extended timeframe.

Institutional Accumulation Meets Insider Liquidation

Institutional shareholders currently hold 94.05% of outstanding LITE shares. During the first quarter, several new institutional positions emerged, including Freemont Management S.A. with an $8.29 million stake, Mediolanum International Funds at $2.87 million, and Hanseatic Management Services with $2.68 million.

Conversely, company insiders have liquidated $38.8 million in shares over the previous 90 days. Director Isaac Hosojiro Harris disposed of 1,416 shares at an average price of $1,000.08 on June 2nd through a predetermined Rule 10b5-1 trading arrangement. SVP Jae Kim sold 1,422 shares at $953.95 during May, with a portion of that sale covering tax liabilities associated with equity compensation vesting.

Over the past twelve months, Lumentum has traded as low as $97.55 and as high as $1,085.68. The stock’s 200-day moving average currently stands at $710.76.

The most recent significant analyst activity came from Citigroup, which added the stock to its 90-day catalyst watch list.

✨ Limited Time Offer